Catalyst Wire Dossier Catalyst Wire Dossier

delpazolid

delpazolid · LigaChem Biosciences, Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for delpazolid, covering 2024-10-28 to 2025-08-22. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Efficacy of Delpazolid as Add-on Therapy in Refractory Mycobacterium Abscessus Complex [Phase 2]

See pricing